- Home
- BCDA
BCDA
BioCardia Inc.
as of 12-03-2025 4:00pm EST
$1.42
+$0.05
+3.65%
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
Chart Type:
Time Range:
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | SUNNYVALE |
| Market Cap: | 15.4M | IPO Year: | N/A |
| Target Price: | $25.00 | AVG Volume (30 days): | 64.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.66 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.00 - $3.20 | Next Earning Date: | 11-12-2025 |
| Revenue: | N/A | Revenue Growth: | -87.84% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered BCDA Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 21 hours ago
AI Recommendation
hold
Model Accuracy: 74.15%
74.15%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest BioCardia Inc. News
BCDA Breaking Stock News: Dive into BCDA Ticker-Specific Updates for Smart Investing
GlobeNewswire
BioCardia to Present at December 2025 CSI Focus Devices in Heart Failure Congress
📊
AI Sentiment
Positive
7/10
Compare BCDA vs Leading Stocks
See how BCDA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "BCDA BioCardia Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.